4506 On Other Exchanges
Symbol
Exchange
4506 is not on other exchanges.

Executive Profile*

Chiang J. Li M.D., FACP.

Executive Officer, Chief Executive Officer of Boston Biomedical, Inc, President of Boston Biomedical, Inc, Head of Global Oncology for Sumitomo Dainippon Pharma Group and Chief Medical Officer of Boston Biomedical, Inc,Sumitomo Dainippon Pharma Co., Ltd.
AgeTotal Calculated CompensationThis person is connected to 22 board members in 2 different organizations across 6 different industries.

See Board Relationships
51--

Background*

Dr. Chiang J. Li, M.D., FACP., serves as the President, Chief Executive Officer and Chief Medical Officer at Boston Biomedical, Inc. (BBI). Dr. Li serves as an Executive Officer and Head of Global Oncology of Sumitomo Dainippon Pharma Co., Ltd. He is the Founder of Cequent Pharmaceuticals, Inc. He serves as Head of Global Oncology at the DSP Group. Dr. Li served as the Chief Scientific Officer at Boston Biomedical, Inc. which he founded it in November 2006. He Founded ...

Read Full Background

Corporate Headquarters*

6-8 Doshomachi 2-chome
Osaka, -- 541-0045

Japan

Phone: 81 6 6203 5321
Fax: 81 6 6202 6028

Board Members Memberships*

Founder, Chairman of the Scientific Advisory Board and Director

Education*

MD
Harvard Medical School
Unknown/Other Education
Harvard-MIT Division of Health Sciences and Technology

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jeffrey J. Clarke Chief Executive Officer and Director
Eastman Kodak Co.
$1.0M
Shigetaka Komori Chairman, Group Chief Executive Officer and Executive Officer
FUJIFILM Holdings Corporation
¥207.0M
Christophe Weber Chief Executive Officer, President and Representative Director
Takeda Pharmaceutical Company Limited
¥230.0M
Dayanand Thandalam Sriram Managing Director, Director, Member of Nomination & Remuneration Committee, Member of Risk Management & Corporate Governance Monitoring Committee, Member of Finance Committee and Member of Administrative Committee
GlaxoSmithKline Consumer Nigeria Plc
--
John Anthony Sedor Chairman, Chief Executive Officer and Member of Nominating Committee
Pernix Therapeutics Holdings, Inc.
--
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SUMITOMO DAINIPPON PHARMA CO, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.